European Companies Search Engine

UK funding (£225,439): Validating heart health benefits of new and improved broccoli variety Ukri 1 May 2012 UK Research and Innovation, United Kingdom

Overview

Text

Validating heart health benefits of new and improved broccoli variety

Abstract An innovative broccoli product with a health claim would enable increased consumption of vegetables and improve public health. Broccoli naturally accumulates significant amounts of the phytonutrient glucoraphanin (GR), the dietary source of sulforaphane implicated in mitigating oxidative stress and inflammation. New commercial broccoli varieties, developed with conventional breeding and derived from UK public research, with improved levels of GR pave the way for a commonly consumed vegetable providing health benefits to UK consumers. This proposal will examine the cardiovascular health benefits of a new GR (Beneforté®) broccoli in comparison to standard broccoli. Proof-of-concept has been obtained with a High GR prototype; this study will provide appropriately powered statistical evidence of health benefit to enable accredited claims and value creation for consumers.
Category Collaborative R&D
Reference 101119
Status Closed
Funded period start 01/05/2012
Funded period end 31/10/2014
Funded value £225,439.00
Source https://gtr.ukri.org/projects?ref=101119

Participating Organisations

MONSANTO UK LIMITED

£14,433.00

UNIVERSITY OF READING

£126,134.00

THE INSTITUTE OF FOOD RESEARCH

£84,872.00

The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Monsanto UK Ltd., Reading.